2m 2m 2m 2m 2m 2m 2m
AbbVie (ABBV)
NYSE
$256.39-$0.73 (-0.28%)
Price as of Sep 11, 2026 7:57 PM EDT- $450.6BMarket Cap
- 21.41%1-Year Change
- Drug Manufacturers - GeneralIndustry
AbbVie (ABBV)
$256.39-$0.73 (-0.28%)
ABBV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $257.12 | ||
Change | +$2.12 (+0.83%) | ||
Open | $253.92 | ||
High | $259.61 | ||
Low | $253.92 | ||
Previous Close | $255.00 | ||
Volume | 4,308,860 | ||
30-Day Average Volume | 4,315,655 | ||
1-Week Change | 0.26% | ||
1-Month Change | 2.81% | ||
1-Year Change | 21.41% | ||
3-Year Change | 91.35% | ||
5-Year Change | 189.57% | ||
Fundamentals | |||
Shares Outstanding | 1.8B | ||
Total Assets | $135.1B | ||
Market Cap | $450.6B | ||
Enterprise Value | $514.9B | ||
Period: QTR TTM FY | |||
Revenue | $17.0B | ||
Net Income | $3.6B | ||
Free Cash Flow | $3.1B | ||
EBIT | $5.0B | ||
EBITDA | $6.6B | ||
Net Working Capital | -$8.0B | ||
EPS | $2.03 | ||
Enterprise Value/EBITDA | 78 | ||
Enterprise Value/Revenue | 30 | ||
P/B | -77 | ||
P/E | 127 | ||
PEG | 0 | ||
Price/Free Cash Flow | 146 | ||
Price/Operating Cash Flow | 132 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.69% | ||
Trailing Annual Dividend Yield | 2.66% | ||
Ex-Dividend Date | 10/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield